| Literature DB >> 11905595 |
Abstract
Bio-reactive advanced glycation endproducts (AGE) alter the structure and function of molecules in biological systems and increase oxidative stress. These adverse effects of both exogenous and endogenously derived AGE have been implicated in the pathogenesis of diabetic complications and changes associated with ageing including atherosclerosis, renal, eye and neurological disease. Specific AGE receptors and nonreceptor mechanisms contribute to these processes but also assist in the removal and degradation of AGE. The final disposal of AGE depends on renal clearance. Promising pharmacologic strategies to prevent AGE formation, reduce AGE toxicity, and/or inactivate AGE are under investigation.Entities:
Mesh：
Substances：
Year: 2002 PMID： 11905595 DOI： 10.1046/j.1365-2796.2002.00932.x
Source DB: PubMed Journal: J Intern Med ISSN： 0954-6820 Impact factor: 8.989